Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

76,147 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Quality-of-life, mental health, and perspective on TKI dose reduction as a prelude to discontinuation in chronic phase chronic myeloid leukemia.
Chen Y, Xu N, Yang Y, Liu Z, Xue M, Meng L, He Q, Chen C, Zeng Q, Zhu H, Du X, Zou J, He W, Guo J, Chen S, Yuan G, Wu H, Hong M, Cheng F, Liu B, Zhang Y, Li W. Chen Y, et al. Among authors: li w. Cancer Med. 2023 Aug;12(16):17239-17252. doi: 10.1002/cam4.6296. Epub 2023 Jul 6. Cancer Med. 2023. PMID: 37409506 Free PMC article.
Comparison of outcomes of idarubicin intensified TBI-CY and traditional TBI-CY conditioning regimen for high-risk acute lymphoblastic leukemia undergoing allogeneic hematopoietic stem cell transplantation: A single center experience.
Wu Q, Zhang R, Wang H, You Y, Zhong Z, Hong M, Fang J, Li W, Shi W, Lu X, Hu Y, Xia L. Wu Q, et al. Among authors: li w. Leuk Res. 2015 Aug 28:S0145-2126(15)30369-6. doi: 10.1016/j.leukres.2015.08.015. Online ahead of print. Leuk Res. 2015. PMID: 26340915
Idarubicin-intensified BUCY2 conditioning regimen improved survival in high-risk acute myeloid, but not lymphocytic leukemia patients undergoing allogeneic hematopoietic stem cell transplantation: A retrospective comparative study.
Fang J, Zhang R, Wang H, Hong M, Wu Q, Nie D, You Y, Zhong Z, Li W, Hu Y, Xia L. Fang J, et al. Among authors: li w. Leuk Res. 2016 Jul;46:61-8. doi: 10.1016/j.leukres.2016.04.014. Epub 2016 Apr 19. Leuk Res. 2016. PMID: 27131062
Monitoring of leukemia stem cells in chronic myeloid leukemia patients.
Cui J, Zhu Z, Liu S, Li Q, Meng L, Cheng H, Zhong Z, Li W, You Y, Zhu X, Zou P. Cui J, et al. Among authors: li w, li q. Leuk Lymphoma. 2018 Sep;59(9):2264-2266. doi: 10.1080/10428194.2017.1421755. Epub 2018 Jan 16. Leuk Lymphoma. 2018. PMID: 29334838 No abstract available.
Corrigendum to 'Idarubicin-intensified BUCY2 conditioning regimen improved survival in high-risk acute myeloid, but not lymphocytic leukemia patients undergoing allogeneic hematopoietic stem cell transplantation: A retrospective comparative study.' [Leuk Res. 2016 Jul;46:61-68.].
Fang J, Zhang R, Wang H, Hong M, Wu Q, Nie D, You Y, Zhong Z, Li W, Hu Y, Xia L. Fang J, et al. Among authors: li w. Leuk Res. 2019 Jun;81:107. doi: 10.1016/j.leukres.2017.06.012. Leuk Res. 2019. PMID: 31109445 No abstract available.
COVID-19 in persons with chronic myeloid leukaemia.
Li W, Wang D, Guo J, Yuan G, Yang Z, Gale RP, You Y, Chen Z, Chen S, Wan C, Zhu X, Chang W, Sheng L, Cheng H, Zhang Y, Li Q, Qin J; Hubei Anti-Cancer Association; Meng L, Jiang Q. Li W, et al. Among authors: li q. Leukemia. 2020 Jul;34(7):1799-1804. doi: 10.1038/s41375-020-0853-6. Epub 2020 May 18. Leukemia. 2020. PMID: 32424293 Free PMC article.
76,147 results
You have reached the last available page of results. Please see the User Guide for more information.